Maven Renovar VCT PLC
The investment objective of Maven Renovar VCT PLC (formerly Amati AIM VCT plc) is to generate tax free capital gains and income on investors' funds, through investment primarily in AIM-traded companies.
Financial highlights
As at 31 January 2025
£111.5m
Net Asset Value
76.41p*
NAV per Ordinary Share
213.75p
NAV Total Return per Ordinary Share
137.34p
Dividends paid to date per Ordinary Share
60
Qualifying investments
17.95%**
Tax free yield
*The NAV per share shown above will be reduced by the payment of any subsequent dividends (see table below).
**Based on average dividends paid or declared in respect of the past five full financial years (including any exceptional payments) and current NAV, for an assumed investment in new shares benefitting from the current 30% initial tax relief available on investment in new VCT shares (ignoring any initial offer costs).
Key information
Ordinary Shares in Issue
(total voting rights)
143,951,488 (at 23 May 2025)
History
Launched - 29 January 2001.
Maven Renovar VCT PLC was known as Amati AIM VCT prior to 1 May 2025, when Maven took over management of the fund from Amati Global Investors. The fund was also previously Amati VCT 2 before 4 May 2018, following a merger between Amati VCT and Amati VCT 2. Amati VCT 2 was itself the result of a merger by scheme of reconstruction between ViCTory VCT and the former Amati VCT 2 (originally Invesco Perpetual AiM VCT).
Registered Office
8th Floor, 100 Bishopsgate, London, EC2N 4AG
Company No. 04138683
Latest/Announced AGM
19 June 2025
Next Continuation Vote
2029
Live Share Price
To view Share Price and LSE announcements please click here.
Data Protection Policy
Dividend Reinvestment Scheme
Currently suspended
Meet the Manager Event
12 June 2025
Maven is hosting a Meet the Manager event at 87 Barts Close, London, where Shareholders in Maven Renovar VCT (formerly Amati AIM VCT) can hear from the senior team managing the Maven VCTs. To find out more or register to attend, please click below.
Performance
NAV Total Return per share
Dividends
The Board aims to pay annual dividends of around 5% of the Company’s Net Asset Value at its immediately preceding financial year end, subject to the Company’s distributable reserves and cash resources, and with the authority to increase or decrease this level at the Directors’ discretion.
Total Dividends (per share) Paid or Declared 147.34p
Year Ended January |
Payment Date |
Interim/final/special |
Rate (p) |
2025 |
30 May 2025 (record date 2 May 2025) |
Special |
10.00 |
|
17 January 2025 |
Special |
2.50 |
|
17 January 2025 |
Second Interim |
1.50 |
|
25 October 2024 |
First Interim |
2.50 |
|
10 June 2024 |
Special |
10.00 |
2024 |
12 January 2024 |
Second Interim |
2.50 |
|
24 November 2023 |
Interim |
2.50 |
2023 |
21 July 2023 |
Final |
3.50 |
|
25 November 2022 |
Interim |
3.50 |
2022 |
22 July 2022 |
Final |
4.50 |
|
26 November 2021 |
Interim |
4.50 |
2021 |
23 July 2021 |
Final |
7.00 |
|
27 November 2020 |
Interim |
3.50 |
2002 - 2020 |
89.34 |
Qualifying Portfolio
Top 10 Investments
1. WS Amati UK Listed Smaller Companies Fund
Listed Fund
Cost £6,977,000| Valuation £11,356,000
% of net asset by value 10.2
2. Learning Technologies Group
Provider of digital learning solutions for organisations
Cost £3,771,000 | Valuation £6,307,000
% of net asset by value 5.7
3. Craneware
Software company that offers services for healthcare
Cost £3,601,000 | Valuation £4,146,000
% of net asset by value 3.7
4. GB Group
Identity verification, location intelligence and fraud prevention
Cost £2,967,000 | Valuation £3,931,000
% of net asset by value 3.5
5. Property Franchise Group
Letting and estate agency
Cost £576,000 | Valuation £3,841,000
% of net asset by value 3.4
6. MaxCyte
Commercial cell engineering
Cost £1,536,000 | Valuation £3,650,000
% of net asset by value 3.3
7. Water Intelligence
Leak detection and remediation services
Cost £1,038,000 | Valuation £3,218,000
% of net asset by value 2.9
8. Chorus Intelligence Limited Ordinary Shares
Investigator software
Cost £301,000 | Valuation £151,000
% of net asset by value 0.1
8. Chorus Intelligence Limited 10% Convertible Loan Notes
Investigator software
Cost £2,699,000 | Valuation £2,699,000
% of net asset by value 2.4
9. Intelligent Ultrasound
Diagnostic imaging
Cost £2,195,000 | Valuation £2,808,000
% of net asset by value 2.5
10. Diaceutics
Diagnostic commercialisation platform for precision medicine
Cost £1,557,000 | Valuation £2,766,000
% of net asset by value 2.5
Shareholder Documents
Maven and the VCTs are committed to reducing the environmental impact of printing substantial documents. If you currently receive hard copy Annual and Interim Reports, and would prefer to receive email or postal notifications of their website publication, you should advise the Registrar, The City Partnership, using the contact details below.
Current Reports and Accounts
See all Historical Reports and Accounts
Shareholder Information
See all Historical Shareholder Information
Board of Directors
Fiona Wollocombe
Non-Executive Chair
Fiona Wollocombe was appointed to the Board in June 2021 and was appointed Chairman at the end of the AGM in June 2022. She is also a non-executive director of Albion Technology & General VCT plc following the merger of Albion VCTs in December 2024. Her previous career was in equity capital markets at NatWest Markets and Deutsche Bank. She has previously held non-executive director roles for a number of other companies in the VCT sector including being chairman of Artemis VCT Plc and of Maven Income and Growth VCT PLC.
Julia Henderson
Non-Executive Director
Julia Henderson joined the Board in May 2018. Prior to this she was a non-executive director of Amati VCT plc which merged with the Company in 2018. She has specialised in advising quoted and unquoted companies for over thirty years. Her corporate finance career began at ANZ Merchant Bank after which she became a co-founder and a director of Beeson Gregory Limited, a mid-market investment bank. Since 2004 she has been an independent consultant, chairman and non-executive director to companies across a broad range of sectors. Previous non-executive directorships include Alkane Energy plc, ECO Animal Health Group plc, GTL Resources plc and TP Group plc.
Brian Scouler
Non-Executive Director
Brian Scouler joined the Board in May 2018. Prior to this he was a non-executive director of Amati VCT plc which merged with the Company in May 2018. He spent 30 years in Private Equity in senior roles with Charterhouse, Royal Bank of Scotland and Dunedin. He has wide experience of buying and selling private companies and investment portfolio management, sitting on numerous investee company boards. He was formerly manager of a quoted investment trust and a member of the steering committee of LPEQ, the listed private equity group. He is a Chartered Accountant.
Neeta Patel
Non-Executive Director
Neeta joined the Board in May 2025. Neeta is a non-executive director of Allianz Technology Trust plc and European Opportunities Trust plc and was previously a director of Albion Venture Capital Trust plc. Neeta's experience includes senior roles at Legal & General, ft.com and the British Council. She was the founding CEO of the Centre for Entrepreneurs, a board adviser at Tech London Advocates, a member of the advisory board at City University Ventures and an entrepreneur mentor-in-residence at London Business School. In October 2020, Neeta was awarded a CBE in the Queen’s Honours list for services to entrepreneurship and technology.
Shareholder Enquiries
For enquiries about your shareholding please contact the registrar The City Partnership:
Call: 01484 240 910
Lines are open 0900 to 1730, Monday to Friday, excluding public holidays in England and Wales. Calls are charged at the standard geographic rate and will vary by provider. Calls from outside the UK will be charged at the applicable international rate.
email: mavencp@city.uk.com
The City Partnership
The Mending Rooms
Park Valley Mills
Meltham Road
Huddersfield, HD4 7BH
Online Portal
Accessing your Shareholding information online
You can register with City’s online Investor Hub to view your shareholding, including indicative valuation, share certificate details, dividend histories, and changes to personal details and communications preferences. To ‘Register’ and create your account you need to enter your Investor Access Token (found on your welcome email or letter from City, your share certificate or contact City for a token), and then simply ‘Login’ each time using the email address and password you provided on registration.
Financial intermediaries – can also register on the hub to view clients’ shareholding details (provided that a letter of authority has been given by the shareholder, or permission granted via a VCT application form). Please contact City with any questions about registering for the hub, or to receive City’s ‘Guide for intermediaries’.